Alliancebernstein L.P. cut its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 0.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 88,178 shares of the medical device company’s stock after selling 281 shares during the quarter. Alliancebernstein L.P. owned approximately 0.18% of Cooper Companies, Inc. (The) worth $21,112,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Wells Fargo & Company MN lifted its holdings in shares of Cooper Companies, Inc. (The) by 17.1% during the second quarter. Wells Fargo & Company MN now owns 178,297 shares of the medical device company’s stock valued at $42,689,000 after acquiring an additional 25,994 shares during the period. Edgestream Partners L.P. bought a new position in shares of Cooper Companies, Inc. (The) during the second quarter valued at $214,000. Commonwealth Bank of Australia lifted its holdings in shares of Cooper Companies, Inc. (The) by 5.2% during the second quarter. Commonwealth Bank of Australia now owns 971 shares of the medical device company’s stock valued at $231,000 after acquiring an additional 48 shares during the period. Tredje AP fonden lifted its holdings in shares of Cooper Companies, Inc. (The) by 80.2% during the second quarter. Tredje AP fonden now owns 26,040 shares of the medical device company’s stock valued at $6,234,000 after acquiring an additional 11,590 shares during the period. Finally, Schroder Investment Management Group lifted its holdings in shares of Cooper Companies, Inc. (The) by 0.9% during the second quarter. Schroder Investment Management Group now owns 510,471 shares of the medical device company’s stock valued at $121,043,000 after acquiring an additional 4,549 shares during the period. 95.79% of the stock is owned by institutional investors.

Cooper Companies, Inc. (NYSE COO) opened at 232.41 on Friday. The company has a 50 day moving average price of $245.08 and a 200-day moving average price of $225.59. The company has a market capitalization of $11.38 billion, a PE ratio of 33.33 and a beta of 0.59. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The company had revenue of $556.00 million during the quarter, compared to the consensus estimate of $552.32 million. During the same period last year, the company earned $2.30 earnings per share. The firm’s revenue was up 8.0% compared to the same quarter last year. On average, analysts anticipate that Cooper Companies, Inc. will post $9.72 EPS for the current year.

A number of research analysts have issued reports on the company. Piper Jaffray Companies lifted their price objective on Cooper Companies, Inc. (The) to $265.00 and gave the company an “overweight” rating in a report on Wednesday, July 19th. BidaskClub cut Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Jefferies Group LLC reissued a “buy” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Stephens reissued an “equal weight” rating and set a $250.00 price objective (up from $235.00) on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Finally, Zacks Investment Research cut Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a report on Thursday, June 22nd. Seven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $257.60.

COPYRIGHT VIOLATION WARNING: This article was first reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.watchlistnews.com/alliancebernstein-l-p-has-21-11-million-holdings-in-cooper-companies-inc-the-coo/1579738.html.

In other news, CEO Paul L. Remmell sold 9,294 shares of the firm’s stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the completion of the transaction, the chief executive officer now directly owns 6,186 shares in the company, valued at $1,536,973.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Randal Golden sold 1,621 shares of the firm’s stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $243.65, for a total value of $394,956.65. Following the transaction, the vice president now owns 1,731 shares of the company’s stock, valued at $421,758.15. The disclosure for this sale can be found here. Insiders have sold 14,992 shares of company stock valued at $3,702,248 over the last 90 days. 1.60% of the stock is owned by corporate insiders.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.